Trial to Assess the Safety and Efficacy of Sirolimus-Coated Balloon vs. Uncoated Standard Angioplasty for the Treatment of Below-the-knee Peripheral Arterial Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 230 participants.

Also called NCT04772300

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 230 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04772300
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Austria, Germany (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04772300. Randomized; double masking; primary purpose treatment. Start 2022-02-10 (actual); primary completion 2026-04-17 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Trial to Assess the Safety and Efficacy of Sirolimus-Coated Balloon vs. Uncoated Standard Angioplasty for the Treatment of Below-the-knee Peripheral Arterial Disease
Acronym
LIMES
Condition
Peripheral Artery Disease
Intervention (Combination product)
Percutaneous Transluminal Angioplasty (PTA) MagicTouch Sirolimus Coated PTA Balloon Catheter
Intervention (Device)
Percutaneous Transluminal Angioplasty (PTA) with non-coated balloon catheter (POBA)
Lead sponsor
Jena University Hospital (class: other)
Collaborator
Concept Medical Inc. (class: industry)
Collaborator
Vascuscience (class: not stated)
Collaborator
CoreLab Black Forest (class: not stated)
Collaborator
Center for Clinical Studies Jena (class: not stated)

Record details

Record id
cardio:ct-nct04772300
Content hash
406273f3eaed25ea4c6f092ef56e9ff92156eda03af3dae660dfb0a8e537ca15